Timing of new black box warnings and withdrawals for prescription medications.

By K. Lasser, P. Allen, S. Woolhandler, D. Himmelstein, S. Wolfe, D. Bor. Journal of the American Medical Association (JAMA), 2002

905 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Predicting in vivo drug interactions from in vitro drug discovery data (2005, background): “Inhibition of these enzymes by co-administered drugs has led to the removal of several drugs from the market during the past 7 year”
Drug‐induced acute liver failure: Results of a U.S. multicenter, prospective study (2010, background): “For practitioners seeing patients with unexplained acute liver disease, comprehensive catalogs of DILI ALF agents are useful, but these lists are only ‘‘snapshots’’ because prescribing practices vary geographically and temporarily.(3,24,34) Few biologicals were implicated here, but DILI from these c”
GRADE guidelines: 2. Framing the question and deciding on important outcomes. (2011, neutral): “Food and Drug Administrationeapproved drugs [15].”